• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Chemical and Biological Properties of (2R)-4-amino-2-hydroxybutanoic acid hydrochloride (CAS No. 117173-81-6)

(2R)-4-amino-2-hydroxybutanoic acid hydrochloride, identified by its CAS number 117173-81-6, is a compound of significant interest in the field of pharmaceutical chemistry and biochemistry. This zwitterionic compound, featuring both amino and hydroxyl functional groups, exhibits unique physicochemical properties that make it a valuable intermediate in the synthesis of various bioactive molecules. The hydrochloride salt form enhances its solubility in aqueous systems, facilitating its application in both in vitro and in vivo studies.

The structure of (2R)-4-amino-2-hydroxybutanoic acid hydrochloride consists of a four-carbon backbone with an L-alanine-like configuration at the second carbon atom, imparting chirality to the molecule. This stereochemical feature is crucial for its biological activity, as enantiomers often exhibit different pharmacological profiles. The presence of both an amino group and a hydroxyl group allows for diverse chemical modifications, making it a versatile building block in drug design and development.

In recent years, (2R)-4-amino-2-hydroxybutanoic acid hydrochloride has garnered attention due to its potential role in the synthesis of novel therapeutic agents. Its zwitterionic nature provides stability under various pH conditions, which is particularly advantageous for formulations intended for oral or parenteral administration. Furthermore, the compound's ability to participate in hydrogen bonding networks makes it a promising candidate for peptidomimetic chemistry, where it can serve as a scaffold to mimic the structure and function of natural peptides.

One of the most compelling aspects of (2R)-4-amino-2-hydroxybutanoic acid hydrochloride is its involvement in the development of enzyme inhibitors. The compound's structural motif is reminiscent of amino acids found in many metabolic pathways, suggesting that it could interact with enzymes involved in these processes. For instance, studies have shown that derivatives of this compound exhibit inhibitory activity against certain proteases and kinases, which are implicated in various diseases such as cancer and inflammation. The precise stereochemistry at the chiral center plays a critical role in determining the binding affinity and specificity of these enzyme-inhibiting derivatives.

Recent advancements in computational chemistry have enabled the design of more sophisticated analogs of (2R)-4-amino-2-hydroxybutanoic acid hydrochloride. By leveraging molecular modeling techniques, researchers have been able to predict the binding modes of this compound with target enzymes at an atomic level. This has led to the identification of novel pharmacophores that could enhance therapeutic efficacy while minimizing side effects. Such computational approaches are particularly valuable in high-throughput screening programs aimed at discovering new drug candidates.

The pharmaceutical industry has also explored the use of (2R)-4-amino-2-hydroxybutanoic acid hydrochloride as a chiral auxiliary in asymmetric synthesis. Chiral auxiliaries are compounds that facilitate the formation of enantiomerically pure products through stereoselective reactions. By incorporating this compound into synthetic protocols, chemists can achieve high yields of enantiomerically enriched intermediates, which are essential for producing single-enantiomer drugs with improved pharmacokinetic profiles.

In addition to its applications in drug discovery, (2R)-4-amino-2-hydroxybutanoic acid hydrochloride has been investigated for its potential role in biomaterials science. Its biodegradability and biocompatibility make it an attractive candidate for developing scaffolds for tissue engineering applications. Researchers have demonstrated that this compound can be used to create porous matrices that support cell growth and differentiation, potentially leading to novel therapeutic strategies for regenerative medicine.

The safety profile of (2R)-4-amino-2-hydroxybutanoic acid hydrochloride has been thoroughly evaluated through preclinical studies. These investigations have revealed that the compound exhibits low toxicity at relevant concentrations, making it suitable for further development into therapeutic agents. However, as with any chemical entity intended for medical use, careful consideration must be given to potential side effects and interactions with other drugs.

The future prospects for (2R)-4-amino-2-hydroxybutanoic acid hydrochloride are promising, given its multifaceted applications across multiple disciplines. Ongoing research aims to expand its utility by exploring new synthetic pathways and biological functions. As our understanding of molecular interactions continues to evolve, compounds like this one will undoubtedly play a pivotal role in shaping the next generation of pharmaceutical innovations.

• 13477-53-7(2-Hydroxy-4-amino Butanoic Acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)